Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate

NCT03990701 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.

NCT NCT03990701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03990701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate
Lead sponsor
Changi General Hospital
Phase
Phase 1
Overall status
Completed
Start date
May 21, 2018
Completion date
March 30, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism, primary aldosteronism due to aldosterone producing adenoma